Get started
Author

Stella J. Bowcock

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
2019 · Alemnew F Dagnew, Osman Ilhan, et al. · The Lancet Infectious Diseases · 279
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
2019 · Mark T Drayson, Stella Bowcock, et al. · The Lancet Oncology · 173
PDF
High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities
2003 · Patrick D. Thornton, Estella Matutes, et al. · Annals of Hematology · 102
Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.
1991 · R Cheingsong-Popov, C Panagiotidi, et al. · BMJ · 80
PDF
Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis
1989 · Finella Brito‐Babapulle, Stella J. Bowcock, et al. · British Journal of Haematology · 73
Guidelines for screening and management of late and long‐term consequences of myeloma and its treatment
2017 · John A. Snowden, Diana M. Greenfield, et al. · British Journal of Haematology · 70
PDF
Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?
2009 · Stella J. Bowcock, Hannah E. Patrick · British Journal of Haematology · 43
PDF
Thromboembolism in Patients on Thalidomide for Myeloma
2002 · Stella J. Bowcock, Saad M.B. Rassam, et al. · Hematology · 40
PDF
F railty-adjusted therapy i n T ransplant N on- E ligible patient s with newly diagno s ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial
2022 · Amy Beth Coulson, Kara-Louise Royle, et al. · BMJ Open · 37
Antibodies to HIV-1 nef (p27): Prevalence, Significance, and Relationship to Seroconversion
1990 · Rachanee Cheingsong-Popov, Christina Panagiotidi, et al. · AIDS Research and Human Retroviruses · 36
Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.
1984 · S J Bowcock, A D Stockdale, et al. · BMJ · 32
PDF
Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome
1989 · Anthony Hammond, Andrew C. Rudge, et al. · Arthritis & Rheumatism · 29
Subcutaneous aprotinin causes local hyperaemia: A possible mechanism by which aprotinin improves control in some diabetic patients
1983 · G. Williams, J. C. Pickup, et al. · Diabetologia · 25
PDF
A prospective study of the incidence of delayed haemolytic transfusion reactions following peri‐operative blood transfusion
1988 · Patricia E. Hewitt, Elizabeth A. Macintyre, et al. · British Journal of Haematology · 24
Immune response to COVID ‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response
2022 · Karthik Ramasamy, Ross Sadler, et al. · British Journal of Haematology · 22
PDF
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs
2019 · Spyros Kolovos, Guido Nador, et al. · Journal of bone oncology · 22
PDF
Tackling Early Morbidity and Mortality in Myeloma (TEAMM): Assessing the Benefit of Antibiotic Prophylaxis and Its Effect on Healthcare Associated Infections in 977 Patients
2017 · Mark T Drayson, Stella Bowcock, et al. · Blood · 19
Time to redefine Myeloma
2015 · Guy Pratt, Stella Bowcock, et al. · British Journal of Haematology · 19
IMWG Frailty Score-Adjusted Therapy Delivery Reduces the Early Mortality Risk in Newly Diagnosed Tne Multiple Myeloma: Results of the UK Myeloma Research Alliance (UK-MRA) Myeloma XIV Fitness Trial
2024 · Gordon Cook, Charlotte Pawlyn, et al. · Blood · 17
High incidence of therapy‐related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders
2006 · Stella J. Bowcock, Saad M. B. Rassam, et al. · British Journal of Haematology · 17
PDF
COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma
2021 · Karthik Ramasamy, Ross Sadler, et al. · British Journal of Haematology · 14
PDF
Survival trends in elderly myeloma patients
2020 · Adam Jones, Stella Bowcock, et al. · European Journal Of Haematology · 14
Dynamic Frailty Assessment in Transplant Non-Eligible Newly Diagnosed Myeloma Patients: Initial Data from UK Myeloma Research Alliance (UK-MRA) Myeloma XIV (FiTNEss): A Frailty-Adjusted Therapy Study
2023 · Gordon Cook, Charlotte Pawlyn, et al. · Blood · 13
Fitness, a UK Myeloma Research Alliance (UK-MRA) Frailty-Adjusted Therapy Study, Supports the Feasibility of Recruiting Frail Newly Diagnosed Myeloma Patients to Large Clinical Trials
2021 · Gordon Cook, Charlotte Pawlyn, et al. · Blood · 13
Frailty-Adjusted Therapy in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (FiTNEss): A UK Myeloma Research Alliance Study, Myeloma XIV
2019 · David Cairns, Charlotte Pawlyn, et al. · Blood · 13
Works count: 90
Citation count: 1,426
H-index: 18
I10-index: 32
Year
Topic
Type